Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The co... Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis.The company's primary sources of revenues include its sales of taliglucerase alfa in Brazil and of drug substance to Pfizer under its Amended Pfizer Agreement. Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.05 | 2.19298245614 | 2.28 | 2.41 | 2.2 | 656031 | 2.33358055 | CS |
| 4 | -0.39 | -14.3382352941 | 2.72 | 2.7299 | 2.2 | 581574 | 2.45105664 | CS |
| 12 | 0.51 | 28.021978022 | 1.82 | 2.76 | 1.6 | 585231 | 2.29212152 | CS |
| 26 | 1.35 | 137.755102041 | 0.98 | 2.76 | 0.98 | 415643 | 1.96812725 | CS |
| 52 | 0.83 | 55.3333333333 | 1.5 | 2.76 | 0.8214 | 373474 | 1.60876278 | CS |
| 156 | 1.4693 | 170.709887301 | 0.8607 | 3.55 | 0.8214 | 846670 | 1.7514423 | CS |
| 260 | -0.46 | -16.4874551971 | 2.79 | 7.02 | 0.7 | 792181 | 2.12076372 | CS |
| Symbol | Preis | Vol. |
|---|---|---|
| SOXLDirexion Daily Semiconductor Bull 3X Shares | US$ 20,88 (8,58%) | 139,35M |
| SPXSDirexion Daily S&P 500 Bear 3X Shares New | US$ 6,69 (-1,47%) | 121,41M |
| MSTUT Rex 2X Long MSTR Daily Target ETF | US$ 6,0701 (-11,51%) | 90,17M |
| XLFFinancial Select Sector | US$ 49,12 (-0,53%) | 85,46M |
| SPYSPDR S&P 500 | US$ 575,92 (0,56%) | 80,19M |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
